RB Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $407K | Sell |
3,383
-1,300
| -28% | -$150K | 0.09% | 137 |
|
|
2025
Q4 | $493K | Buy |
4,683
+577
| +14% | +$54.2K | 0.1% | 131 |
|
|
2025
Q3 | $345K | Sell |
4,106
-738
| -15% | -$60.8K | 0.07% | 144 |
|
|
2025
Q2 | $383K | Sell |
4,844
-713
| -13% | -$56.7K | 0.09% | 133 |
|
|
2025
Q1 | $499K | Sell |
5,557
-318
| -5% | -$29.7K | 0.12% | 119 |
|
|
2024
Q4 | $584K | Sell |
5,875
-145
| -2% | -$14.9K | 0.13% | 107 |
|
|
2024
Q3 | $684K | Sell |
6,020
-247
| -4% | -$29.3K | 0.16% | 103 |
|
|
2024
Q2 | $776K | Sell |
6,267
-753
| -11% | -$97K | 0.19% | 89 |
|
|
2024
Q1 | $926K | Buy |
7,020
+466
| +7% | +$57.4K | 0.24% | 79 |
|
|
2023
Q4 | $715K | Sell |
6,554
-157
| -2% | -$16.3K | 0.2% | 90 |
|
|
2023
Q3 | $691K | Buy |
6,711
+37
| +0.6% | +$3.99K | 0.22% | 85 |
|
|
2023
Q2 | $770K | Sell |
6,674
-48
| -0.7% | -$5.45K | 0.23% | 89 |
|
|
2023
Q1 | $715K | Buy |
6,722
+288
| +4% | +$31.1K | 0.23% | 91 |
|
|
2022
Q4 | $714K | Sell |
6,434
-93
| -1% | -$9.51K | 0.25% | 83 |
|
|
2022
Q3 | $562K | Buy |
6,527
+42
| +0.6% | +$3.75K | 0.22% | 91 |
|
|
2022
Q2 | $591K | Buy |
6,485
+47
| +0.7% | +$4.17K | 0.22% | 88 |
|
|
2022
Q1 | $528K | Buy |
6,438
+2
| +0% | +$158 | 0.17% | 102 |
|
|
2021
Q4 | $493K | Buy |
6,436
+274
| +4% | +$21.8K | 0.15% | 112 |
|
|
2021
Q3 | $463K | Buy |
6,162
+35
| +0.6% | +$2.66K | 0.17% | 107 |
|
|
2021
Q2 | $477K | Sell |
6,127
-445
| -7% | -$33.1K | 0.18% | 106 |
|
|
2021
Q1 | $483K | Sell |
6,572
-554
| -8% | -$40.9K | 0.21% | 95 |
|
|
2020
Q4 | $556K | Sell |
7,126
-301
| -4% | -$23K | 0.26% | 83 |
|
|
2020
Q3 | $576K | Sell |
7,427
-96
| -1% | -$7.52K | 0.27% | 74 |
|
|
2020
Q2 | $555K | Buy |
7,523
+436
| +6% | +$32.8K | 0.29% | 77 |
|
|
2020
Q1 | $520K | Buy |
7,087
+19
| +0.3% | +$1.49K | 0.33% | 69 |
|
|
2019
Q4 | $615K | Buy |
7,068
+35
| +0.5% | +$2.88K | 0.35% | 70 |
|
|
2019
Q3 | $566K | Buy |
7,033
+474
| +7% | +$38K | 0.36% | 70 |
|
|
2019
Q2 | $525K | Buy |
6,559
+1,001
| +18% | +$76.6K | 0.38% | 70 |
|
|
2019
Q1 | $441K | Buy |
5,558
+29
| +0.5% | +$2.17K | 0.36% | 69 |
|
|
2018
Q4 | $403K | Buy |
5,529
+22
| +0.4% | +$1.55K | 0.41% | 65 |
|
|
2018
Q3 | $373K | Sell |
5,507
-209
| -4% | -$13.3K | 0.33% | 76 |
|
|
2018
Q2 | $331K | Buy |
5,716
+149
| +3% | +$8.41K | 0.25% | 89 |
|
|
2018
Q1 | $289K | Sell |
5,567
-464
| -8% | -$25.1K | 0.23% | 92 |
|
|
2017
Q4 | $324K | Buy |
6,031
+30
| +0.5% | +$1.66K | 0.23% | 90 |
|
|
2017
Q3 | $367 | Buy |
6,001
+1,194
| +25% | +$72.4K | ﹤0.01% | 78 |
|
|
2017
Q2 | $294K | Buy |
4,807
+24
| +0.5% | +$1.46K | 0.25% | 91 |
|
|
2017
Q1 | $290K | Buy |
4,783
+109
| +2% | +$6.61K | 0.27% | 84 |
|
|
2016
Q4 | $263K | Buy |
+4,674
| New | +$274K | 0.26% | 86 |
|
Other funds holding MRK
VCM
VPM
RB Capital Management's MRK Position: Q1 2026 in Review
RB Capital Management reduced its Merck (MRK) stake by 28% in Q1 2026, selling an estimated $150K and leaving 3,383 shares worth $407K. The position accounts for 0.09% of the portfolio, ranked #137.
RB Capital Management first reported a position in MRK in Q4 2016 and has held it in 38 quarters since. The position peaked at $926K in Q1 2024. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- RB Capital Management held 3,383 shares of Merck worth $407K as of Q1 2026.
- RB Capital Management sold 1,300 Merck shares in Q1 2026, an estimated $150K.
- Merck made up 0.09% of RB Capital Management's portfolio in Q1 2026, its #137 holding.
- RB Capital Management first reported a position in Merck in Q4 2016 and has held it in 38 quarters since.
- RB Capital Management's Merck position peaked at $926K in Q1 2024.
- 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on RB Capital Management's 13F filing for Q1 2026, filed 15 May 2026.